Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,313 | 31,555 | 63,754 | 44,488 | 42,018 |
| Marketable Securities | 109,383 | 126,679 | 109,259 | 129,473 | 135,522 |
| Receivables | 38 | 8 | 14,089 | 1,369 | 1,539 |
| Other current assets | 2,119 | 2,153 | 2,162 | 2,688 | 2,179 |
| TOTAL | $155,853 | $160,395 | $189,264 | $178,018 | $181,258 |
| Non-Current Assets | |||||
| PPE Net | 1,876 | 1,784 | 1,900 | 2,034 | 1,861 |
| Investments And Advances | 12,749 | 17,410 | 480 | 8,865 | 14,634 |
| Other Non-Current Assets | 4,335 | 4,335 | 4,335 | 4,334 | 4,334 |
| TOTAL | $18,960 | $23,529 | $6,715 | $15,233 | $20,829 |
| Total Assets | $174,813 | $183,924 | $195,979 | $193,251 | $202,087 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,348 | 1,460 | 911 | 1,416 | 1,420 |
| Accrued Expenses | 8,185 | 6,577 | 8,094 | 8,130 | 6,937 |
| TOTAL | $14,573 | $13,878 | $15,646 | $23,113 | $29,152 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,638 | 5,345 | 6,052 | 13,287 | 20,522 |
| Other Non-Current Liabilities | 2,068 | 2,030 | 1,992 | 2,175 | 2,110 |
| TOTAL | $24,224 | $25,093 | $25,961 | $26,833 | $28,202 |
| Total Liabilities | $38,797 | $38,971 | $41,607 | $49,946 | $57,354 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,062 | 66,732 | 66,509 | 66,385 | 66,325 |
| Common Shares | 67 | 67 | 66 | 66 | 66 |
| Retained earnings | -743,990 | -731,748 | -719,673 | -729,163 | -726,085 |
| Other shareholders' equity | -44 | -44 | -2 | 19 | -143 |
| TOTAL | $136,016 | $144,953 | $154,372 | $143,305 | $144,733 |
| Total Liabilities And Equity | $174,813 | $183,924 | $195,979 | $193,251 | $202,087 |